(Q38633806)

5 September 2017

1 reference

title

Clinical impact of newer quinolones: influence on normal microflora (English)

1 reference

5 September 2017

0 references

Nord CE

1

1 reference

5 September 2017

Edlund C

series ordinal

2

1 reference

5 September 2017

publication date

1 February 1989

1 reference

5 September 2017

published in

Journal of Chemotherapy

1 reference

5 September 2017

volume

1

1 reference

5 September 2017

issue

1

1 reference

5 September 2017

page(s)

18-23

1 reference

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

[Clinical study of the effectiveness and tolerance of norfloxacin in the therapy of complicated urinary tract infections and in long-term prevention of recurrent urinary tract infections].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1120009X.1989.11738858

10.1080/1120009X.1989.11738858

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference